The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,675 followers.

RT @FrontOncology: New research: The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial…

05 Feb 2024

Reply Repost Favourite

New research: The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs: Background TP53 mutation is a poor factor for non-small cell lung cancer (NSCLC), while… https://t.c

05 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.